Citations

Showing 10 of 108083 citations.

Increasing Severity of Malnutrition Is Associated With Poorer 30-Day Outcomes in Patients Undergoing Hip Fracture Surgery
Chung, Andrew S. , Jones, Clifford B. , Lowe, Jason , Russell, George V., Chung, Andrew , Hustedt, Joshua W. , WALKER, ROBERT E.

Mayo Clinic

Journal of Orthopaedic Trauma | November 21, 2017 | Volume: 32 | Issue: 4 | Pages: 155-160

10.1097/bot.0000000000001081 | PMID 29558371 Get It

Objectives: Low serum albumin levels (hypoalbuminemia) have classically been used to identify malnutrition. The effect of increasing severity of malnutrition on postoperative outcomes in patients undergoing hip fracture surgery has not been well delineated on a large scale. Design: Retrospective. Setting: Multicenter. Patient/Participants: A total of 12,373 patients undergoing hip fracture surgery from 2006 to 2013 National Surgery Quality Improvement Project data were identified. Intervention: Patient demographic, comorbidity, and preoperative laboratory data and complication, reoperation, and readmission data were collected. Main Outcome Measurements: Multivariate logistic regression was used to determine the effect of increasing severity of malnutrition on rates of 30-day postoperative complications, readmissions, and reoperations. Results: A total of 12,373 hip fractures met inclusion criteria. A total of 6506 (52.6%) patients had normal albumin levels (albumin ≥3.5 g/dL), 3205 (25.9%) patients were mildly malnourished (albumin 3.1–3.49 g/dL), 2265 (18.3%) were moderately malnourished (albumin 2.4–3.1 g/dL), and 397 (3.2%) patients were severely malnourished (albumin <2.4 g/dL). Mean age was similar between the 4 cohorts (P < 0.001). Severe malnutrition was associated with a 2-fold increase in the odds of postoperative complications and mortality when compared with mild malnutrition (P < 0.001). Increasing severity of malnutrition was associated with significantly longer lengths of stay and higher odds of experiencing a related readmission (P < 0.001). Conclusions: Increasing severity of hypoalbuminemia is independently associated with poorer outcomes in the 30 days after hip fracture surgery. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
Guest Editorial: Discovery and Artificial Intelligence
King, Bernard F.

Mayo Clinic

American Journal of Roentgenology | November 21, 2017 | Volume: 209 | Issue: 6 | Pages: 1189-1190

10.2214/ajr.17.19178 | PMID 29161146 Get It

Craniosynostosis Surgery and the Impact of Tranexamic Acid Dosing
Kurnik, Nicole M. , Pflibsen, Lacey R. , Do, Annie, Bristol, Ruth E., Singh, Davinder

Mayo Clinic

Journal of Craniofacial Surgery | November 21, 2017 | Volume: 29 | Issue: 1 | Pages: 96-98

10.1097/scs.0000000000004196 | PMID 29194278 Get It

Abstract Consensus does not exist regarding the best dosage regimen for using tranexamic acid (TXA) for patients undergoing open calvarial vault remodeling in craniosynostosis surgery. The purpose of this study was to evaluate 2 dosing protocols, as well as the cost of using TXA. Previously, the institutional protocol was to give patients undergoing open calvarial vault remodeling a loading infusion of TXA (10 mg/kg) at the start of their procedure, after which intravenous TXA (5 mg/kg/h) was given throughout surgery and for 24 hours postoperatively. In July 2015, the protocol changed to a reduced postoperative infusion time of 4 hours. A retrospective review was conducted of records of 30 patients who had surgery before the protocol change (24-hour group) and 23 patients whose surgery occurred after the protocol change (4-hour group). The following data were collected: blood volume transfused, hemoglobin levels, estimated blood loss, and intensive care days; and costs of TXA and blood transfusion. Results showed a 4-hour infusion was as effective as a 24-hour infusion for reducing blood loss in patients undergoing craniosynostosis. Transfusion requirements, hemoglobin and hematocrit levels, and estimated blood loss were not significantly different for the groups. The cost of TXA and transfusion in the 4-hour group was significantly less (P < 0.001) than in the 24-hour group. No significant difference in cost existed for patients who received blood transfusion alone versus patients who received the 4-hour TXA infusion.
Patient-Reported Symptom Monitoring During Chemotherapy—Reply
Basch, Ethan , Deal, Allison M. , Dueck, Amylou C. , Dueck, A. C. , Basch, Ethan , Deal, Allison

Mayo Clinic

JAMA | November 21, 2017 | Volume: 318 | Issue: 19 | Pages: 1935

10.1001/jama.2017.14903 | PMID 29164251 Get It

Neuroendovascular Fellowship Training: Self-Assessment of a Program Accredited by the Committee on Advanced Subspecialty Training
Shallwani, Hussain , Rangel-Castilla, Leonardo , Bregy, Amadé , Sonig, Ashish , Ogilvy, Christopher S. , Hopkins, L. Nelson , Siddiqui, Adnan H. , Siddiqui, Adnan H , Shakir, Hakeem J , Rangel-Castilla, Leonardo , Davies, Jason M. , Snyder, Kenneth V. , Levy, Elad I. , Ogilvy, Christopher S

Mayo Clinic

Neurosurgery | November 21, 2017 | Volume: 82 | Issue: 3 | Pages: 407-413

10.1093/neuros/nyx593 | PMID 29351626 Get It

Abstract The University at Buffalo's neuroendovascular fellowship is one of the longest running fellowship programs in North America. The burgeoning neurointerventional workforce and the rapid growth in the neurointerventional space on the heels of groundbreaking clinical trials prompted us to assess the fellowship's academic impact and its graduates’ perceptions and productivity. An anonymized web-based survey was sent to all former neuroendovascular fellows with specific questions pertaining to current practice, research and funding, and perceptions about the fellowship's impact on their skills, competitiveness, and compensation. Additionally, the h -index was calculated to assess the academic productivity of each graduated fellow. Among 50 former fellows, 42 (84%) completed the survey. The fellows came from various countries, ethnic backgrounds, and specialties including neurosurgery (n = 39, 93%), neurology (n = 2, 5%), and neuroradiology (n = 1, 2%). Twenty (48%) respondents were currently chairs or directors of their practice. Most (n = 30, 71%) spent at least 10% of their time on research activities, with 27 (64%) receiving research funding. The median h -index of all 50 former fellows was 14. The biggest gains from the fellowship were reported to be improvement in endovascular skills (median = 10 on a scale of 0-10 [highest]) and increase in competitiveness for jobs in vascular neurosurgery (median = 10), followed by increase in academic productivity (median = 8), and knowledge of vascular disease (median = 8). In an era with open calls for moratoriums on endovascular fellowships, concerns over market saturation, and pleas to improve training, fellowship programs perhaps merit a more objective assessment. The effectiveness of a fellowship program may best be measured by the academic impact and leadership roles of former fellows.
Considerations in the Care of Athletes With Attention Deficit Hyperactivity Disorder
Pujalte, George G.A. , Maynard, Jennifer R. , Thurston, McKennan J., Taylor, Walter C., Chauhan, Mohit , Pujalte, George , Chauhan, Mohit

Mayo Clinic

Clinical Journal of Sport Medicine | November 21, 2017 | Volume: 29 | Issue: 3 | Pages: 245-256

10.1097/jsm.0000000000000508 | PMID 29189334 Get It

Objectives: Uncover literature pertaining to: (1) attention deficit hyperactivity disorder (ADHD) and how it impacts athletes; (2) ADHD medication effects; (3) regulations regarding ADHD medications; (4) approaches to conditions similar to, and occurring with, ADHD; and (5) use of stimulants. Data Sources: MEDLINE, Embase, PsycINFO, Cochrane Database of Systematic Reviews, Ovid interface. Main Results: ADHD can have many effects on athletes and sports participation. Exercise has positive benefits on ADHD behaviors and players' attitudes. Athletes with ADHD can have worsened ADHD symptoms after concussions. Attention deficit hyperactivity disorder is a modifier of return to play; baseline ADHD symptoms should be used to guide management. Management should include medications, behavioral/psychosocial therapy, and academic accommodations. Behavioral therapy combined with medication is superior to behavioral treatment alone. Sustained exercise as ADHD treatment should be considered mainstay in management. Sports can increase thermogenic effects of stimulants, heat injury, and cardiac arrhythmias. Increased aggressiveness, improved pain tolerance, and decreased sense of fatigue are some attributes of stimulants that are presumed to impart some advantage to athletes, but evidence is uncertain. Attention deficit hyperactivity disorder medications may lead to myocardial infarctions, cerebrovascular accidents, paranoid psychoses, seizures, insomnia, tremors, anxiety, hypertension, and death. Conclusions: Athletes' performance and quality of life can be negatively affected by ADHD. Risks exist for those who take ADHD medications. More research is needed on the implications ADHD may have in specific sports, and on possible advantages of medication use. Potential deleterious effects of these medications should be addressed.
TMEM106B and myelination: rare leukodystrophy families reveal unexpected connections
Zhou, Xiaolai , Rademakers, Rosa

Mayo Clinic

Brain | November 21, 2017 | Volume: 140 | Issue: 12 | Pages: 3069-3080

10.1093/brain/awx318 | PMID 29194508 Get It

Gene Delivery to Joints by Intra-Articular Injection
Evans, Christopher H. , Ghivizzani, Steven C. , Robbins, Paul D.

Mayo Clinic

Human Gene Therapy | November 21, 2017 | Volume: 29 | Issue: 1 | Pages: 2-14

10.1089/hum.2017.181 | PMID 29160173 Get It

Most forms of arthritis are incurable, difficult to treat, and a major cause of disability in Western countries. Better local treatment of arthritis is impaired by the pharmacokinetics of the joint that make it very difficult to deliver drugs to joints at sustained, therapeutic concentrations. This is especially true of biologic drugs, such as proteins and RNA, many of which show great promise in preclinical studies. Gene transfer provides a strategy for overcoming this limitation. The basic concept is to deliver cDNAs encoding therapeutic products by direct intra-articular injection, leading to sustained, endogenous synthesis of the gene products within the joint. Proof of concept has been achieved for both in vivo and ex vivo gene delivery using a variety of vectors, genes, and cells in several different animal models. There have been a small number of clinical trials for rheumatoid arthritis (RA) and osteoarthritis (OA) using retrovirus vectors for ex vivo gene delivery and adeno-associated virus (AAV) for in vivo delivery. AAV is of particular interest because, unlike other viral vectors, it is able to penetrate deep within articular cartilage and transduce chondrocytes in situ. This property is of particular importance in OA, where changes in chondrocyte metabolism are thought to be fundamental to the pathophysiology of the disease. Authorities in Korea have recently approved the world's first arthritis gene therapy. This targets OA by the injection of allogeneic chondrocytes that have been transduced with a retrovirus carrying transforming growth factor-β 1 cDNA. Phase III studies are scheduled to start in the United States soon. Meanwhile, two additional Phase I trials are listed on Clinicaltrials.gov , both using AAV. One targets RA by transferring interferon-β, and the other targets OA by transferring interleukin-1 receptor antagonist. The field is thus gaining momentum and promises to improve the treatment of these common and debilitating diseases.
Mycobacterium genavenseinfections in non-HIV immunocompromised hosts: a systematic review
Mahmood, Maryam , Ajmal, Saira , Saleh, Omar Abu , Bryson, Alexandra , Marcelin, Jasmine R , Wilson, John , Abu Saleh, Omar M, Marcelin, Jasmine , Mahmood, Maryam

Mayo Clinic

Infectious Diseases | November 21, 2017 | Volume: 50 | Issue: 5 | Pages: 329-339

10.1080/23744235.2017.1404630 | PMID 29157060 Get It

Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions
Konrad‐Martin, Dawn , Poling, Gayla L. , Garinis, Angela C. , Ortiz, Candice E., Hopper, Jennifer, Bennett, Keri O., Dille, Marilyn F.

Mayo Clinic

International Journal of Audiology | November 21, 2017 | Volume: 57 | Issue: sup4 | Pages: S3-S18

10.1080/14992027.2017.1398421 | PMID 29157038 Get It